Selectively oncolytic mutant of HSV-1 lyses HeLa cells mediated by Ras/RTN3.

The selectively oncolytic mtHSV, a HSV icp34.5 mutant with lacz gene insertion, was proved that it was targeted for treating tumors but not other organs, however, its oncolytic mechanism is under confirmation. The results showed that HeLa cells could be lysed efficiently by mtHSV in vitro. In the flow cytometry and Western blot experiment, Ras protein was obviously down-regulated on plasma membrane (PM) while the whole Ras protein didn’t change along with up-regulation of reticulon 3(RTN3) protein at 48h post infection of mtHSV in HeLa cells . Expression of Ras protein on PM and whole Ras protein in HeLa cells was down-regulated by siFTa（inhibitor ofαsubunits of human farnesyltransferase with siRNA）and siRTN3(inhibitor of RTN3 with siRNA) respectively, and HeLa cells could be killed effectively by siFTa and siRTN3 at 48h post transfection. So siFTa and siRTN3 effectively suppressed mtHSV infection of HeLa cells. Further, experiments were made to study the relationship between Ras and RTN3 using confocal c...